Compliance Rate
Compliance Rate
48.0%
Compliant submissions
48
Incompliant submissions
52
Total trials
100
Your Clinical Trials
Showing 25 of 100 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/02/22
End: 01/04/22
Due: 01/05/22
Phase: N/A
Priority: Normal
Start: 01/12/22
End: 01/14/22
Due: 01/15/22
Phase: N/A
Priority: Normal
Start: 01/22/22
End: 01/24/22
Due: 01/25/22
Phase: N/A
Priority: Normal
Start: 02/01/22
End: 02/03/22
Due: 02/04/22
Phase: N/A
Priority: Normal
Start: 02/11/22
End: 02/13/22
Due: 02/14/22
Phase: N/A
Priority: Normal
Start: 02/21/22
End: 02/23/22
Due: 02/24/22
Phase: N/A
Priority: Normal
Start: 03/03/22
End: 03/05/22
Due: 03/06/22
Phase: N/A
Priority: Normal
Start: 03/13/22
End: 03/15/22
Due: 03/16/22
Phase: N/A
Priority: Normal
Start: 03/23/22
End: 03/25/22
Due: 03/26/22
Phase: N/A
Priority: Normal
Start: 04/02/22
End: 04/04/22
Due: 04/05/22
Phase: N/A
Priority: Normal
Start: 04/12/22
End: 04/14/22
Due: 04/15/22
Phase: N/A
Priority: Normal
Start: 12/28/22
End: 12/30/22
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 04/10/97
End: 02/13/02
Due: 02/13/03
Phase: N/A
Priority: Normal
Start: 04/30/99
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/92
End: 12/31/98
Due: 12/31/99
Phase: N/A
Priority: Normal
Start: 09/30/85
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/85
End: 11/30/89
Due: 11/30/90
Phase: N/A
Priority: Normal
Start: -
End: 06/30/05
Due: 06/30/06
Phase: N/A
Priority: Normal
Start: -
End: 12/31/92
Due: 12/31/93
Phase: N/A
Priority: Normal
Start: 01/31/85
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 09/30/02
Due: 09/30/03
Phase: N/A
Priority: Normal
Start: 09/30/91
End: 09/30/96
Due: 09/30/97
Phase: N/A
Priority: Normal
Start: 12/31/88
End: 10/31/93
Due: 10/31/94
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/31/99
End: 10/31/06
Due: 10/31/07
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study 1 | NCT00000000 | Organization 1 | user1@example.com | Compliant | 2022-01-02 | 2022-01-04 | 2022-01-05 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 11 | NCT00000010 | Organization 11 | user1@example.com | Compliant | 2022-01-12 | 2022-01-14 | 2022-01-15 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 21 | NCT00000020 | Organization 21 | user1@example.com | Incompliant | 2022-01-22 | 2022-01-24 | 2022-01-25 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 31 | NCT00000030 | Organization 31 | user1@example.com | Compliant | 2022-02-01 | 2022-02-03 | 2022-02-04 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 41 | NCT00000040 | Organization 41 | user1@example.com | Compliant | 2022-02-11 | 2022-02-13 | 2022-02-14 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 51 | NCT00000050 | Organization 51 | user1@example.com | Incompliant | 2022-02-21 | 2022-02-23 | 2022-02-24 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 61 | NCT00000060 | Organization 61 | user1@example.com | Incompliant | 2022-03-03 | 2022-03-05 | 2022-03-06 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 71 | NCT00000070 | Organization 71 | user1@example.com | Incompliant | 2022-03-13 | 2022-03-15 | 2022-03-16 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 81 | NCT00000080 | Organization 81 | user1@example.com | Compliant | 2022-03-23 | 2022-03-25 | 2022-03-26 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 91 | NCT00000090 | Organization 91 | user1@example.com | Incompliant | 2022-04-02 | 2022-04-04 | 2022-04-05 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 101 | NCT00000100 | Organization 1 | user1@example.com | Compliant | 2022-04-12 | 2022-04-14 | 2022-04-15 | 2025-07-01 | Clinician | 2025-07-01 |
| Study 361 | NCT00000360 | Organization 61 | user1@example.com | Incompliant | 2022-12-28 | 2022-12-30 | 2022-12-31 | 2025-07-01 | Clinician | 2025-07-01 |
| Naltrexone Maintenance Treatment of Alcoholism | NCT00000450 | The Scripps Research Institute | user1@example.com | Incompliant | 1997-04-10 | 2002-02-13 | 2003-02-13 | 2025-07-01 | - | 2025-07-14 |
| Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22 | NCT00000240 | University of Vermont | user1@example.com | Compliant | 1999-04-30 | - | - | 2025-07-01 | - | 2025-07-14 |
| Coronary Artery Bypass Graft (CABG) Patch Trial | NCT00000540 | National Heart, Lung, and Blood Institute (NHLBI) | user1@example.com | Incompliant | 1992-12-31 | 1998-12-31 | 1999-12-31 | 2025-07-01 | - | 2025-07-14 |
| The Silicone Study | NCT00000140 | National Eye Institute (NEI) | user1@example.com | Incompliant | 1985-09-30 | - | - | 2025-07-01 | - | 2025-07-14 |
| Prevention of Coronary Aneurysms in Kawasaki Syndrome | NCT00000520 | National Heart, Lung, and Blood Institute (NHLBI) | user1@example.com | Compliant | 1985-07-31 | 1989-11-30 | 1990-11-30 | 2025-07-01 | - | 2025-07-14 |
| AIT-082 Phase 1B Study | NCT00000180 | National Institute on Aging (NIA) | user1@example.com | Incompliant | - | 2005-06-30 | 2006-06-30 | 2025-07-01 | - | 2025-07-14 |
| Phase I Safety and Immunogenicity Trial of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (gp160; VaxSyn) | NCT00000630 | National Institute of Allergy and Infectious Diseases (NIAID) | user1@example.com | Incompliant | - | 1992-12-31 | 1993-12-31 | 2025-07-01 | - | 2025-07-14 |
| Clinical Trial of Eye Prophylaxis in the Newborn | NCT00000120 | National Eye Institute (NEI) | user1@example.com | Compliant | 1985-01-31 | - | - | 2025-07-01 | - | 2025-07-14 |
| Sertraline and Naltrexone for Alcohol Dependence | NCT00000440 | National Institute on Alcohol Abuse and Alcoholism (NIAAA) | user1@example.com | Incompliant | - | 2002-09-30 | 2003-09-30 | 2025-07-01 | - | 2025-07-14 |
| Multicenter Unsustained Tachycardia Trial (MUSTT) | NCT00000480 | National Heart, Lung, and Blood Institute (NHLBI) | user1@example.com | Compliant | 1991-09-30 | 1996-09-30 | 1997-09-30 | 2025-07-01 | - | 2025-07-14 |
| Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest | NCT00000470 | Boston Children's Hospital | user1@example.com | Incompliant | 1988-12-31 | 1993-10-31 | 1994-10-31 | 2025-07-01 | - | 2025-07-14 |
| A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea | NCT00000980 | Rhone-Poulenc Rorer | user1@example.com | Compliant | - | - | - | 2025-07-01 | - | 2025-07-14 |
| Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV | NCT00000940 | National Institute of Allergy and Infectious Diseases (NIAID) | user1@example.com | Compliant | 1999-05-31 | 2006-10-31 | 2007-10-31 | 2025-07-01 | - | 2025-07-14 |